Kyverna Therapeutics
Biotechnology, 5980 Horton St, Emeryville, California, 94608, United States, 51-200 Employees
Phone Number: 13*********
Who is KYVERNA THERAPEUTICS
Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic pl...
Read More
-
Headquarters: 5980 Horton St, Emeryville, California, 94608, United States
-
Date Founded: 2018
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from KYVERNA THERAPEUTICS
Kyverna Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Kyverna Therapeutics
Answer: Kyverna Therapeutics's headquarters are located at 5980 Horton St, Emeryville, California, 94608, United States
Answer: Kyverna Therapeutics's phone number is 13*********
Answer: Kyverna Therapeutics's official website is https://kyvernatx.com
Answer: Kyverna Therapeutics's revenue is $10 Million to $25 Million
Answer: Kyverna Therapeutics's SIC: 2834
Answer: Kyverna Therapeutics has 51-200 employees
Answer: Kyverna Therapeutics is in Biotechnology
Answer: Kyverna Therapeutics contact info: Phone number: 13********* Website: https://kyvernatx.com
Answer: Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyvernas pipeline includes KYV-101, a fully human, autologous chimeric antigen receptor (CAR) T-cell therapy with properties well suited for use in B cell-driven autoimmune diseases and KYV-201, a fully human, allogeneic CAR T-cell therapy. By offering more than one mechanism for taming autoimmunity, and with patients currently in treatment for multiple indications in the U.S. and Europe, Kyverna is positioned to act on its mission of transforming how autoimmune diseases are treated.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month